In what way does Ezetimibe affect hepatic cholesterol stores?

Ezetimibe primarily works by inhibiting the absorption of cholesterol from the intestine, which leads to a reduction in the amount of cholesterol available to the liver. As a result, when dietary and biliary cholesterol absorption is decreased, the liver senses a reduction in its cholesterol store. To compensate for this lower cholesterol availability, the liver increases the uptake of circulating LDL cholesterol from the blood, which ultimately leads to decreased levels of cholesterol in the liver.

This mechanism explains why choosing the option indicating that Ezetimibe decreases hepatic cholesterol stores is accurate. By lowering the overall cholesterol levels available for the liver to use, Ezetimibe effectively reduces the hepatic cholesterol pool, prompting adjustments in lipid metabolism and contributing to lower blood cholesterol levels.